1. Zarrinpar A, Busuttil RW. Liver transplantation: past, present and future. Nat Rev Gastroenterol Hepatol. 2013;10(7):434-40. doi:10.1038/nrgastro.2013.88 2. Moini M, Schilsky ML, Tichy EM. Review on immunosuppression in liver transplantation. World J Hepatol. 2015;7(10):1355. doi: 10.4254/wjh.v7.i10.1355 3. Baumann AK, Schlue J, Noyan F, Hardtke‐Wolenski M, Lehner F, Barg‐Hock H, et al. Preferential accumulation of T helper cells but not cytotoxic T cells characterizes benign subclinical rejection of human liver allografts. Liver Transpl. 2016;22(7):943-55. [ DOI:10.1002/lt.24427] 4. Sood S, Testro AG. Immune monitoring post liver transplant. World J Transplant. 2014;4(1):30. doi: 10.5500/wjt.v4.i1.30 5. Wang Y, Tang Z, Gao W, Jiang Y, Peng L. Influence of Th1, Th2, and Th3 cytokines during the early phase after liver transplantation. Transplant Proc. 2003. Dec;35(8):3024-5. doi: 10.1016/j.transproceed. 2003.10.007. 6. Ganschow R, Broering D, Nolkemper D, Albani J, Kemper M, Rogiers X, et al. Th2 cytokine profile in infants predisposes to improved graft acceptance after liver transplantation. Transplantation. 2001;72(5):929-34. doi: 10.1097/00007890-200109150-00031 7. Assadiasl S, Toosi MN, Mohebbi B, Ansaripour B, Soleimanifar N, Sadr M, et al. Th17/Treg cell balance in stable liver transplant recipients. Transpl Immunol. 2022;71:101540. doi: 10.1016/j.trim.2022.101540. 8. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-γ: An overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75(2):163-89. doi: 10.1189/jlb.0603252. 9. Millán O, Rafael-Valdivia L, San Segundo D, Boix F, Castro-Panete MJ, López-Hoyos M, et al. Should IFN-γ, IL-17 and IL-2 be considered predictive biomarkers of acute rejection in liver and kidney transplant? Results of a multicentric study. Clin Immunol. 2014;154(2):141-54. doi: 10.1016/j.clim.2014.07.007. 10. Lord R, Goto S, Pan T-L, Chiang K-C, Chen C-L, Sunagawa M. Peak Protein Expression of Il-2 And Ifn-Γ Correlate with The Peak Rejection Episode In a Spontaneously Tolerant Model of Rat Liver Transplantation. Cytokine. 2001;13(3):155-61. doi: 10.1006/cyto.2000.0815. 11. Niu J, Yue W, Song Y, Zhang Y, Qi X, Wang Z, et al. Prevention of acute liver allograft rejection by IL-10-engineered mesenchymal stem cells. Clin Exp Immunol. 2014;176(3):473-84. doi: 10.1111/cei.12283. 12. Wan R, Tang L, Shan R, Zeng L, Chen H, Gao L. Humoral immunity-mediated chronic rejection in liver transplantation is associated with predominant IL-10 expression. Front Biosci (Elite Ed). 2012;4:2121-30. doi: 10.2741/529. 13. Mariotti J, Foley J, Ryan K, Buxhoeveden N, Kapoor V, Amarnath S, et al. Graft rejection as a Th1-type process amenable to regulation by donor Th2-type cells through an interleukin-4/STAT6 pathway. Blood .2008;112(12):4765-75. doi: 10.1182/blood-2008-05-154278 14. Heeger PS. T-cell allorecognition and transplant rejection: a summary and update. Am J Transplant. 2003;3(5):525-33. doi: 10.1034/j.1600-6143.2003.00123.x. 15. Amarnath S, Chen H, Foley JE, Costanzo CM, Sennesh JD, Solomon MA, et al. Host-based Th2 cell therapy for prolongation of cardiac allograft viability. PLoS One. 2011;6(4):e18885. doi: 10.1371/journal.pone.0018885. 16. Liu Z, Fan H, Jiang S. CD4+ T‐cell subsets in transplantation. Immunol rev. Immunol Rev. 2013 Mar;252(1):183-91. doi: 10.1111/imr.12038. 17. Ganschow R, Broering DC, Nolkemper D, Albani J, Kemper MJ, Rogiers X, et al. Th2 cytokine profile in infants predisposes to improved graft acceptance after liver transplantation. Transplantation. 2001 Sep 15;72(5):929-34. doi: 10.1097/00007890-200109150-00031. 18. Chen Y, Chen J, Liu Z, Liang S, Luan X, Long F, et al. Relationship Between TH1/TH2 Cytokines and Immune Tolerance in Liver Transplantation in Rats. Transplant Proc. 2008;40(8):2691-5. doi: 10.1016/j.transproceed.2008.08.014. 19. Wang Yl, Tang Zq, Gao W, Jiang Y, Zhang Xh, Peng L. Influence of Th1, Th2, and Th3 cytokines during the early phase after liver transplantation. Transplant Proc. 2003;35(8):3024-5. doi: 10.1016/j.transproceed.2003.10.007. 20. Park CS, Moon HY, Han S, Chon JY, Chae MS, Hong SH, et al. Ischemic time of graft liver forces Th1-to-Th2 activity toward Th1 activity in patients who underwent living donor liver transplantation. Eur Cytokine Netw. 2019;30(1):23-8. doi: 10.1684/ecn.2019.0422. 21. Demirkiran A, Kok A, Kwekkeboom J, Metselaar HJ, Tilanus HW, van der Laan LJ. Decrease of CD4+CD25+ T cells in peripheral blood after liver transplantation: association with immunosuppression. Transplant Proc. 2005;37(2):1194-6. doi: 10.1016/j.transproceed.2004.12.095. 22. Li S, Yu J, Guo C, Jie Y, Pan Z. The Balance of Th1/Th2 and LAP+Tregs/Th17 Cells Is Crucial for Graft Survival in Allogeneic Corneal Transplantation. J Ophthalmol. 2018;2018:5404989. doi: 10.1155/2018/5404989. 23. Assadiasl S, Mooney N, Nicknam MH. Cytokines in Liver Transplantation. Cytokine. 2021;148:155705. doi: 10.1016/j.cyto.2021.155705. 24. Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol. 2010;10(3):170-81. doi: 10.1038/nri2711. 25. Hassan L, Bueno P, Ferrón-Celma I, Ramia J, Garrote D, Muffak K, et al. Early postoperative response of cytokines in liver transplant recipients. Transplant Proc. 2006 Oct;38(8):2488-91. doi: 10.1016/j.transproceed.2006.08.054. 26. König R, Kolte A, Ahlers O, Oswald M, Krauss V, Roell D, et al. Use of IFNγ/IL10 Ratio for Stratification of Hydrocortisone Therapy in Patients With Septic Shock. Front Immunol. 2021 Mar 9:12:607217. doi: 10.3389/fimmu.2021.607217. 27. Ala Y, Pasha MK, Rao RN, Komaravalli PL, Jahan P. Association of IFN-γ : IL-10 Cytokine Ratio with Nonsegmental Vitiligo Pathogenesis. Autoimmune Dis. 2015;2015:423490-. doi: 10.1155/2015/423490. 28. Giunta EF, Barra G, De Falco V, Argenziano G, Napolitano S, Vitale P, et al. Baseline IFN-γ and IL-10 expression in PBMCs could predict response to PD-1 checkpoint inhibitors in advanced melanoma patients. Sci Rep. 2020;10(1):17626. doi: 10.1038/s41598-020-72711-2. 29. van den Boogaardt DE, van Miert PP, de Vaal YJ, de Fijter JW, Claas FH, Roelen DL. The ratio of interferon-gamma and interleukin-10 producing donor-specific cells as an in vitro monitoring tool for renal transplant patients. Transplantation. 2006;82(6):844-8. doi: 10.1097/01.tp.0000229448.64363.18. 30. Attia F, Kheder E, Khalil K, Tawfik G, Omar W, Anani M. Assessment of Interferon Gamma and Interleukin-10 m-RNA Expression in Peripheral Blood From Renal Transplanted Patients with Chronic Allograft Nephropathy by Real Time Polymerase Chain Reaction. Austin J Nephrol Hypertens. 2015;2(5):1050. id1050 (2015) 31. Chen Y, Chen J, Liu Z, Liang S, Luan X, Long F, et al. Relationship between TH1/TH2 cytokines and immune tolerance in liver transplantation in rats. Transplant Proc. 2008 Oct;40(8):2691-5. doi: 10.1016/j.transproceed.2008.08.014.
|